Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02710578
Other study ID # 114/2014
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 2016
Est. completion date July 18, 2017

Study information

Verified date January 2019
Source Centre for Addiction and Mental Health
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Given the known driving behavior of Driving Under the Influence of Alcohol and some of its parallel to driving under the influence of cannabis, this supplemental study aims to validate the sensitivity of the primary and secondary outcome measures employed in a cannabis and driving study currently in progress.


Description:

This study will examine the effects of an intoxicating dose of alcohol on driving-related skills among young drivers using driving simulator technology.

This study is a double-blind, placebo-controlled mixed design study, including randomized between-subjects comparison of the effects of alcohol intoxication and both between- and within-subjects examination of acute and residual effects at approximately 24 and 48 hours following one-time alcohol administration.

Initial contact with potential participants will be made by telephone, where study personnel will conduct a telephone screen for eligibility. Those telephone screened as eligible will attend CAMH for an eligibility assessment. Enrolled participants will complete four sessions on consecutive days: a practice day, an alcohol administration day, and a 24-hour and 48-hour post-alcohol session.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date July 18, 2017
Est. primary completion date July 18, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 19 Years to 25 Years
Eligibility Inclusion Criteria:

- Males and females aged 19 to 25.

- Reported consumption of at least 1 heavy drinking episode (according to NIAAA criteria of 5 drinks for males and 4 for females within an occasion) in the 6 months prior to eligibility assessment.

- Held a valid class G or G2 Ontario driver's license (or equivalent from another jurisdiction) for at least 12 months.

- Willing to abstain from alcohol use for the duration of the study, and for 48 hours prior to Session 2.

- Provides written and informed consent.

Exclusion Criteria:

- Taking medications or have any medical condition for which alcohol is contraindicated

- Is a regular user of medications that affect brain function (i.e., antidepressants, benzodiazepines, stimulants).

- Diagnosis of severe medical or psychiatric conditions.

- Meets criteria for current or lifetime Substance Use Disorders (DSM-IV) with the exception of nicotine.

- Meets criteria for Alcohol Dependence (DSM-IV)

- Is pregnant, is trying to become pregnant, or is currently breastfeeding.

- Severe allergic reaction to citrus.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Alcohol
A single oral administration of an alcoholic beverage mixed in a 1:3 ratio of alcohol (Vodka) to tonic water to obtain a target BAC of 0.08mg%
Placebo
A single oral administration of a beverage containing tonic water of the same volume as the alcoholic beverage.

Locations

Country Name City State
Canada Centre for Addiction and Mental Health Toronto Ontario

Sponsors (2)

Lead Sponsor Collaborator
Centre for Addiction and Mental Health Ontario Ministry of Transportation

Country where clinical trial is conducted

Canada, 

References & Publications (1)

Lenné MG, Dietze PM, Triggs TJ, Walmsley S, Murphy B, Redman JR. The effects of cannabis and alcohol on simulated arterial driving: Influences of driving experience and task demand. Accid Anal Prev. 2010 May;42(3):859-66. doi: 10.1016/j.aap.2009.04.021. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Psychomotor impairment (driving) The driving simulator will objectively measure changes in driving behaviour after drinking alcohol. Approximate Time Frame: 30 minutes before, 30 minutes after, 24 and 48 hours after drinking
Secondary Subjective alcohol effects Visual analogue scale measures how participants feel before and after drinking alcohol. administration. Approximate Time Frame: 30 minutes before drinking, 5, 15, 30 minutes and 1, 2, 3, 24 and 48 hours post-drinking
Secondary Cognitive testing Changes in Continuous Performance Test performance. Approximate Time Frame: 30 minutes before drinking, and 1, 24 and 48 hours post-drinking
Secondary Breath alcohol content (BAC) Changes in BAC after drinking Approximate Time Frame: 30 minutes before drinking, 5, 15, 30, minutes and 1, 2, 3, 24, and 48 hours post-drinking
See also
  Status Clinical Trial Phase
Completed NCT03297944 - Sedative-Anxiolytic Effects on Simulated Driving Performance Phase 4
Completed NCT03104296 - Correlation Between Cerebral Oxygenation and Neurodevelopment in VLBW Preterm Infants. N/A
Completed NCT03106363 - Combined Alcohol and Cannabis Effects on Skills of Young Drivers Early Phase 1
Completed NCT01592409 - Cannabis Effects on Driving-related Skills of Young Drivers N/A
Recruiting NCT04288531 - Iodine Impact on Thyroid Function and Psychomotor Development, Observational Study in the Portuguese Minho Region